Imbio Segmentation Editing Tool software
K-Number: K180129 · 2018-03-16
ApplicantImbio, LLC
Decision Date2018-03-16
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent
Device Summary
Imbio Segmentation Editing Tool software is a medical device manufactured by Imbio, LLC. It received FDA 510(k) clearance on 2018-03-16 under approval number K180129. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Imbio Segmentation Editing Tool software?
Imbio Segmentation Editing Tool software is a medical device that received FDA 510(k) clearance on 2018-03-16. It is manufactured by Imbio, LLC. The 510(k) number is K180129.
When was Imbio Segmentation Editing Tool software approved by the FDA?
Imbio Segmentation Editing Tool software received FDA 510(k) clearance on 2018-03-16, under approval number K180129.
What company makes Imbio Segmentation Editing Tool software?
Imbio Segmentation Editing Tool software is manufactured by Imbio, LLC.
What is the FDA product code for Imbio Segmentation Editing Tool software?
The FDA product code for Imbio Segmentation Editing Tool software is LLZ.
Other Devices by Imbio, LLC
Related Devices (Code: LLZ)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.